Mork Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Hold |
30,000
| – | – | 1.01% | 30 |
|
|
2025
Q1 | $1.83M | Hold |
30,000
| – | – | 1.43% | 14 |
|
|
2024
Q4 | $1.7M | Hold |
30,000
| – | – | 1.12% | 21 |
|
|
2024
Q3 | $1.55M | Hold |
30,000
| – | – | 1.11% | 27 |
|
|
2024
Q2 | $1.25M | Hold |
30,000
| – | – | 0.98% | 35 |
|
|
2024
Q1 | $1.63M | Hold |
30,000
| – | – | 1.23% | 20 |
|
|
2023
Q4 | $1.54M | Hold |
30,000
| – | – | 0.95% | 24 |
|
|
2023
Q3 | $1.74M | Hold |
30,000
| – | – | 1.36% | 16 |
|
|
2023
Q2 | $1.92M | Hold |
30,000
| – | – | 1.47% | 12 |
|
|
2023
Q1 | $2.08M | Hold |
30,000
| – | – | 1.69% | 5 |
|
|
2022
Q4 | $2.16M | Hold |
30,000
| – | – | 1.66% | 3 |
|
|
2022
Q3 | $2.13M | Hold |
30,000
| – | – | 2.09% | 2 |
|
|
2022
Q2 | $2.31M | Hold |
30,000
| – | – | 2.12% | 2 |
|
|
2022
Q1 | $2.19M | Hold |
30,000
| – | – | 1.98% | 4 |
|
|
2021
Q4 | $1.87M | Hold |
30,000
| – | – | 1.27% | 15 |
|
|
2021
Q3 | $1.78M | Hold |
30,000
| – | – | 1.51% | 20 |
|
|
2021
Q2 | $2.01M | Hold |
30,000
| – | – | 1.45% | 22 |
|
|
2021
Q1 | $1.89M | Hold |
30,000
| – | – | 1.44% | 22 |
|
|
2020
Q4 | $1.86M | Hold |
30,000
| – | – | 1.36% | 15 |
|
|
2020
Q3 | $1.81M | Hold |
30,000
| – | – | 1.98% | 7 |
|
|
2020
Q2 | $1.76M | Hold |
30,000
| – | – | 2.07% | 6 |
|
|
2020
Q1 | $1.67M | Hold |
30,000
| – | – | 2.29% | 3 |
|
|
2019
Q4 | $1.93M | Hold |
30,000
| – | – | 1.38% | 10 |
|
|
2019
Q3 | $1.52M | Hold |
30,000
| – | – | 1.39% | 15 |
|
|
2019
Q2 | $1.36M | Hold |
30,000
| – | – | 1.26% | 26 |
|
|
2019
Q1 | $1.43M | Buy |
+30,000
| New | +$1.43M | 1.33% | 22 |
|